Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S17-S19, 30 November 2006

How to start insulin treatment: Earlier or delayed insulin therapy

Section of Endocrinology and Metabolism, Department of Medicine, Marmara University Medical School, Istanbul, Turkey

published online 25 September 2006.

Abstract 

No consensus exists as to the best time for starting insulin treatment in patients with type 2 diabetes. Glucose toxicity is a significant factor which affects the approach to treatment at various stages of the disease. Those who advocate early insulin use cite studies which have used CSII or intensive insulin therapy in newly-diagnosed type 2 diabetics and have achieved long-term glycemic control without medication, similar to the “honeymoon” in type 1 diabetic patients. Although there are studies showing improved control with maximal dose sulfonylurea therapy, glucose control takes longer to achieve and HbA1c levels remain higher than current targets. It is evident that without insulin, our patients will perpetually remain below target and suffer the consequences of hyperglycaemia, even if mild.

Keywords: Early insulin treatment, Type 2 diabetes mellitus, Glucotoxicity, Diabetic complications

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(06)00256-7

doi:10.1016/j.diabres.2006.06.008

Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S17-S19, 30 November 2006